The median MDM2 levels in sensitive and resistant subgroups were 8 versus 4 ng/μg, and 10 versus 3 ng/μg in FLT3wt and FLT3-ITD NK-AML respectively. Here, FLT3 is linked to acute myeloid leukemia.